Publikace
- Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency2023 | 2. lékařská fakulta
- Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs2022 | 2. lékařská fakulta
- SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients2022 | 2. lékařská fakulta
- Oncostatin M and Nivolumab Affect the Cytotoxic T-Cell Proportions and the Susceptibility to TRAIL-Induced Death in Non-Leukocyte Cell Subpopulations in Soft Tissue Sarcomas2023 | 2. lékařská fakulta, 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade2023 | 2. lékařská fakulta, 1. lékařská fakulta
- Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies2023 | 2. lékařská fakulta
- Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?2023 | 2. lékařská fakulta
- Gastrointestinal Involvement in Primary Antibody Deficiencies2023 | 2. lékařská fakulta
- Content and specificity of the Anti-SARS-CoV-2 antibodies in solutions for immunoglobulin replacement therapy2023 | 2. lékařská fakulta
- Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study2022 | 2. lékařská fakulta, 1. lékařská fakulta, Lékařská fakulta v Plzni, Lékařská fakulta v Hradci Králové
Loading network view...